HIND vs IVF
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 03, 2026
HIND
IVF
Investment Advisor Scores
IVF
AI Analyst Insights
Detailed Metrics Comparison
| Metric | HIND | IVF | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -46.0% | 16.7% | IVF |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 55.6/100 | 29.2/100 | HIND |
| Profit Margin | 0.0% | -92.3% | HIND |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | STRONG BUY | AVOID NEW MONEY | HIND |
Relative Price Performance (Last 90 Days)
Current Technical Phase
HIND
MarkdownPrice below a falling SMA50 (slope -8.7%), weak momentum, RSI 25
IVF
MarkupPrice above SMA50, rising 50-day trend (3.8% over 20 days), RSI 86
Fundamentals Snapshot
| Metric | HIND | IVF |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -1.9 | -0.1 |
| Trailing P/E | 0.9 | 0.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.5% | 0.2% |
| Gross Margin | 0.5% | 0.4% |
| Operating Margin | -32.0% | -0.6% |
| EPS | 1.78 | 511.80 |
| Dividend Yield | — | — |